Alnylam Pharmaceuticals recently presented comprehensive results from a clinical trial for its drug, vutrisiran, aimed at treating transthyretin…
This article 28% lower risk of death, 33% risk reduction—Could this be the new standard of care for a deadly heart condition? 🤔 appeared first on Guerilla Stock Trading.
First Solar (NASDAQ:FSLR) Shares Down 5.5% – Time to Sell? Source link
Want to create a stream of income that flows into your account without you having to punch a clock every day? Investing in dividend-paying stocks can be a really interesting way to achieve this financial goal! By carefully selecting dividend stocks and allocating a significant sum, say $25,000, you can potentially build a steady and…
Quite a few readers and viewers have been asking me on and off this year whether I was adding to my investment in Wilmar. I think more people asked me when Wilmar’s stock price went down to $3.20 and $3.10 per share. I kept saying that I was waiting for $3.00 per share. Briefly in…
Yesterday, the dollar fell in response to news that U.S. President Donald Trump had appointed Council of Economic Advisers Chair Steven Miran as a member of the Federal Reserve Board of Governors. “He has been with me since the start of my second term, and his experience in the world of economics is unmatched. I…
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable…
Indian equities slipped for a third straight session on Tuesday, November 25, as a volatile derivatives expiry day dragged the Sensex and Nifty lower, with heavyweights ICICI Bank, HDFC Bank, Infosys, ITC, L&T and Kotak Mahindra Bank weighing on the indices. The S&P BSE Sensex dropped 314 points, or 0.37%, to close at 84,587 while…